<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01393327</url>
  </required_header>
  <id_info>
    <org_study_id>S-488/2009</org_study_id>
    <nct_id>NCT01393327</nct_id>
  </id_info>
  <brief_title>Feasibility and Influence of Exercise Therapy on Oxygen Uptake and Right Heart Function in CTEPH Patients After PEA</brief_title>
  <official_title>Feasibility and Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Heart Function in Chronic Thromboembolic Pulmonary Hypertension After Thromboendarterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of this study is to investigate whether and to what extent a cautious respiratory and&#xD;
      movement therapy can complement medical treatment and the condition, oxygen uptake, quality&#xD;
      of life, the pulmonary vascular pressures, the size of the right heart and the 6-minute walk&#xD;
      distance in patients with pulmonary hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of acute pulmonary&#xD;
      embolism. According to current knowledge, it is caused by non-resolving fibrothrombotic&#xD;
      obstructions of large pulmonary arteries. Some patients show an additional small vessel&#xD;
      vasculopathy. Both kinds of obstruction lead to an increase in pulmonary vascular resistance&#xD;
      (PVR), increase in mean pulmonary arterial pressure (mPAP), progressive right heart failure,&#xD;
      and premature death if left untreated. Current guidelines recommend pulmonary endarterectomy&#xD;
      (PEA) as the potentially curative treatment of first choice, which aims to remove fibrotic&#xD;
      obstructions from the pulmonary vasculature. The survival of patients undergoing PEA surgery&#xD;
      ranges between 76 and 91% after 3 years, which is superior to medical treatment in inoperable&#xD;
      CTEPH patients. The majority of operated patients experience almost complete normalisation of&#xD;
      haemodynamics and improvements in symptoms. However, 17-51% of operated patients will develop&#xD;
      persistent or recurrent pulmonary hypertension (PH). Some patients remain limited in their&#xD;
      exercise capacity and prognosis. As patients are monitored on an intensive care unit&#xD;
      immediately after PEA, immobilisation after the operation may lead to further peripheral&#xD;
      deconditioning. A recent study of 251 CTEPH patients with follow-up until 12 months after PEA&#xD;
      showed a persistent exercise limitation in almost 40% of patients despite normalisation of&#xD;
      PVR and haemodynamics. This limitation was characterised by a multifactorial aetiology also&#xD;
      involving respiratory function abnormalities. Previous studies in patients with inoperable or&#xD;
      persistent CTEPH have suggested beneficial effects of exercise training as an add-on to&#xD;
      targeted medical therapy, increasing exercise capacity, and quality of life (QoL). However,&#xD;
      it is not known, whether early rehabilitation with exercise treatment is safe, feasible, and&#xD;
      may further improve exercise capacity after PEA. Prospective studies on exercise training for&#xD;
      CTEPH patients shortly after PEA surgery are lacking. Furthermore, to the best of our&#xD;
      knowledge, there have been no studies yet describing the early effect within the first weeks&#xD;
      after PEA. The aim of this study was therefore to assess the feasibility of supervised&#xD;
      exercise training in CTEPH patients shortly after PEA. Furthermore, changes of haemodynamic&#xD;
      and clinical parameters including oxygen uptake, QoL, exercise capacity, and right heart&#xD;
      function assessed by echocardiography and right heart catheterisation were obtained before&#xD;
      and shortly after PEA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Completion rate of exercise rehabilitation program training by CTEPH patients directly after PEA</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Assessment of feasibility and tolerance of exercise rehabilitation directly after PEA assessed by the number of patients completing the exercise rehabilitation program</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of peak O2 uptake (VO2peak) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Change of peak O2 uptake measured by cardiopulmonary exercise test (CPET)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in right atrial pressure (RAP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in right atrial pressure (RAP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in right ventricular pressure (RVP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in right ventricular pressure (RVP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic pulmonary arterial pressure (sPAP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic pulmonary arterial pressure (sPAP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diastolic pulmonary arterial pressure (dPAP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diastolic pulmonary arterial pressure (dPAP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean pulmonary arterial pressure (mPAP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean pulmonary arterial pressure (mPAP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulmonary arterial wedge pressure (PAWP) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulmonary arterial wedge pressure (PAWP) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac output (CO) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac output (CO) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulmonary vascular resistance (PVR) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulmonary vascular resistance (PVR) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in venous oxygen saturation from pulmonary artery (SvO2) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in venous oxygen saturation from pulmonary artery (SvO2) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac index (CI) at rest</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac index (CI) during exercise</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Changes in hemodynamics during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity assessed by six minute walking test</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Six Minute Walking distance (6MWD) in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity - workload</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>recumbent bike (Workload in Watts) during cycle Ergometer test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity - respiratory economy</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>EqO2, EqCO2 assessed during cardiopulmonary exercise testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of laboratory parameters of right heart function</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Measurement of NT-proBNP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in right atrial area</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Change of cm2 of right atrial area measured by 2D echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in right ventricular area</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Change of cm2 of right ventricular area measured by 2D echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in visual right heart pump function</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>Change of category of right heart pump function (no impairment, slight impairment, moderate impairment, severe impairment) measured by 2D echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of early rehabilitation directly after pulmonary endarterectomy: number of adverse events and serious adverse events</measure>
    <time_frame>up to 15 weeks after start of rehabilitation with exercise training</time_frame>
    <description>number of adverse events and serious adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>CTEPH</condition>
  <arm_group>
    <arm_group_label>Respiratory and exercise therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early after PEA postoperative three-week inpatient rehabilitation and subsequent continuing of the training at home for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>respiratory and exercise therapy</intervention_name>
    <description>Conventional therapy with diet, massage, relaxation baths, plus easy strolls specific respiratory and physical therapy plus mental walking training</description>
    <arm_group_label>Respiratory and exercise therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consent form&#xD;
&#xD;
          -  men and women&gt; 18 years &lt;80 years&#xD;
&#xD;
          -  CTEPH after pulmonary endarterectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with signs of right heart decompensation&#xD;
&#xD;
          -  acute diseases, infections, fever&#xD;
&#xD;
          -  Serious lung disease with FEV1 &lt;50% or TLC &lt;70% of target&#xD;
&#xD;
          -  Other exclusion criteria are the following diseases: active myocarditis, unstable&#xD;
             angina pectoris, exercise-induced ventricular arrhythmias, congestive heart failure,&#xD;
             significant heart disease, pacemakers, and hypertrophic obstructive cardiomyopathy, or&#xD;
             a highly reduced left ventricular function&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ekkehard Grünig, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Center for pulmonary hypertension, Thoraxclinic Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for pulmonary Hypertension, Thoraxclinic Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.</citation>
    <PMID>26826181</PMID>
  </results_reference>
  <results_reference>
    <citation>Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.</citation>
    <PMID>26320113</PMID>
  </results_reference>
  <results_reference>
    <citation>Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999 Aug;160(2):523-8.</citation>
    <PMID>10430723</PMID>
  </results_reference>
  <results_reference>
    <citation>Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7. doi: 10.1164/rccm.200712-1841OC. Epub 2008 Feb 21.</citation>
    <PMID>18292468</PMID>
  </results_reference>
  <results_reference>
    <citation>Skoro-Sajer N, Marta G, Gerges C, Hlavin G, Nierlich P, Taghavi S, Sadushi-Kolici R, Klepetko W, Lang IM. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax. 2014 Feb;69(2):116-22. doi: 10.1136/thoraxjnl-2013-203746. Epub 2013 Sep 19.</citation>
    <PMID>24052543</PMID>
  </results_reference>
  <results_reference>
    <citation>Matsuda H, Ogino H, Minatoya K, Sasaki H, Nakanishi N, Kyotani S, Kobayashi J, Yagihara T, Kitamura S. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006 Oct;82(4):1338-43; discussion 1343.</citation>
    <PMID>16996930</PMID>
  </results_reference>
  <results_reference>
    <citation>Wieteska M, Biederman A, Kurzyna M, Dyk W, Burakowski J, Wawrzyńska L, Szturmowicz M, Fijałkowska A, Szatkowski P, Torbicki A. Outcome of Medically Versus Surgically Treated Patients With Chronic Thromboembolic Pulmonary Hypertension. Clin Appl Thromb Hemost. 2016 Jan;22(1):92-9. doi: 10.1177/1076029614536604. Epub 2014 May 28.</citation>
    <PMID>24875780</PMID>
  </results_reference>
  <results_reference>
    <citation>Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, Kim NH, Wang C, Wilkins MR, Fritsch A, Davie N, Colorado P, Mayer E. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015 May;45(5):1293-302. doi: 10.1183/09031936.00087114. Epub 2014 Nov 13.</citation>
    <PMID>25395036</PMID>
  </results_reference>
  <results_reference>
    <citation>Fukui S, Ogo T, Goto Y, Ueda J, Tsuji A, Sanda Y, Kumasaka R, Arakawa T, Nakanishi M, Fukuda T, Takaki H, Yasuda S, Ogawa H, Nakanishi N. Exercise intolerance and ventilatory inefficiency improve early after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2015 Feb 1;180:66-8. doi: 10.1016/j.ijcard.2014.11.187. Epub 2014 Nov 26.</citation>
    <PMID>25438215</PMID>
  </results_reference>
  <results_reference>
    <citation>Corsico AG, D'Armini AM, Conio V, Sciortino A, Pin M, Grazioli V, Di Vincenzo G, Di Domenica R, Celentano A, Vanini B, Grosso A, Gini E, Albicini F, Merli VN, Ronzoni V, Ghio S, Klersy C, Cerveri I. Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants. Respir Res. 2019 Feb 14;20(1):34. doi: 10.1186/s12931-019-1002-5.</citation>
    <PMID>30764853</PMID>
  </results_reference>
  <results_reference>
    <citation>Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth HJ, Opitz C, Ulrich S, Egenlauf B, Grünig E. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J. 2016 Jan 1;37(1):35-44. doi: 10.1093/eurheartj/ehv337. Epub 2015 Jul 31.</citation>
    <PMID>26231884</PMID>
  </results_reference>
  <results_reference>
    <citation>Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012 Jul;40(1):84-92. doi: 10.1183/09031936.00123711. Epub 2012 Feb 9.</citation>
    <PMID>22323570</PMID>
  </results_reference>
  <results_reference>
    <citation>Lankeit M, Krieg V, Hobohm L, Kölmel S, Liebetrau C, Konstantinides S, Hamm CW, Mayer E, Wiedenroth CB, Guth S. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31877-6. doi: 10.1016/j.healun.2017.06.011. [Epub ahead of print]</citation>
    <PMID>28750932</PMID>
  </results_reference>
  <results_reference>
    <citation>Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med. 2014 Aug 1;190(3):252-7. doi: 10.1164/rccm.201402-0269PP.</citation>
    <PMID>24869464</PMID>
  </results_reference>
  <results_reference>
    <citation>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9. Epub 2006 Sep 18.</citation>
    <PMID>16982941</PMID>
  </results_reference>
  <results_reference>
    <citation>Grünig E, Biskupek J, D'Andrea A, Ehlken N, Egenlauf B, Weidenhammer J, Marra AM, Cittadini A, Fischer C, Bossone E. Reference ranges for and determinants of right ventricular area in healthy adults by two-dimensional echocardiography. Respiration. 2015;89(4):284-93. doi: 10.1159/000371472. Epub 2015 Mar 7.</citation>
    <PMID>25765954</PMID>
  </results_reference>
  <results_reference>
    <citation>Grünig E, Henn P, D'Andrea A, Claussen M, Ehlken N, Maier F, Naeije R, Nagel C, Prange F, Weidenhammer J, Fischer C, Bossone E. Reference values for and determinants of right atrial area in healthy adults by 2-dimensional echocardiography. Circ Cardiovasc Imaging. 2013 Jan 1;6(1):117-24. doi: 10.1161/CIRCIMAGING.112.978031. Epub 2012 Nov 29.</citation>
    <PMID>23197080</PMID>
  </results_reference>
  <results_reference>
    <citation>Leung Wai Sang S, Morin JF, Hirsch A. Operative and Functional Outcome After Pulmonary Endarterectomy for Advanced Thromboembolic Pulmonary Hypertension. J Card Surg. 2016 Jan;31(1):3-8. doi: 10.1111/jocs.12646. Epub 2015 Nov 4.</citation>
    <PMID>26537658</PMID>
  </results_reference>
  <results_reference>
    <citation>Li YD, Zhai ZG, Wu YF, Yang YH, Gu S, Liu Y, Su PX, Wang C. Improvement of right ventricular dysfunction after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of echocardiography to demonstrate restoration of the right ventricle during 2-year follow-up. Thromb Res. 2013 May;131(5):e196-201. doi: 10.1016/j.thromres.2013.02.001. Epub 2013 Feb 27.</citation>
    <PMID>23453712</PMID>
  </results_reference>
  <results_reference>
    <citation>Raza F, Vaidya A, Lacharite-Roberge AS, Lakhter V, Al-Maluli H, Ahsan I, Boodram P, Dass C, Rogers F, Keane MG, Weaver S, Bashir R, Toyoda Y, Forfia P. Initial clinical and hemodynamic results of a regional pulmonary thromboendarterectomy program. J Cardiovasc Surg (Torino). 2018 Jun;59(3):428-437. doi: 10.23736/S0021-9509.17.10188-6. Epub 2017 Sep 4.</citation>
    <PMID>28870062</PMID>
  </results_reference>
  <results_reference>
    <citation>Kepez A, Sunbul M, Kivrak T, Eroglu E, Ozben B, Yildizeli B, Mutlu B. Evaluation of improvement in exercise capacity after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: correlation with echocardiographic parameters. Thorac Cardiovasc Surg. 2014 Feb;62(1):60-5. doi: 10.1055/s-0033-1336012. Epub 2013 Apr 5.</citation>
    <PMID>23564536</PMID>
  </results_reference>
  <results_reference>
    <citation>La Rovere MT, Pinna GD, Pin M, Bruschi C, Callegari G, Zanotti E, D'Armini A, Ambrosino N. Exercise Training After Pulmonary Endarterectomy for Patients with Chronic Thromboembolic Pulmonary Hypertension. Respiration. 2019;97(3):234-241. doi: 10.1159/000492754. Epub 2018 Oct 5.</citation>
    <PMID>30293071</PMID>
  </results_reference>
  <results_reference>
    <citation>Guth S, Wiedenroth CB, Rieth A, Richter MJ, Gruenig E, Ghofrani HA, Arlt M, Liebetrau C, Prüfer D, Rolf A, Hamm CW, Mayer E. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J. 2018 Sep 17;52(3). pii: 1800458. doi: 10.1183/13993003.00458-2018. Print 2018 Sep.</citation>
    <PMID>30139773</PMID>
  </results_reference>
  <results_reference>
    <citation>Adams V, Reich B, Uhlemann M, Niebauer J. Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H72-H88. doi: 10.1152/ajpheart.00470.2016. Epub 2017 May 5. Review.</citation>
    <PMID>28476924</PMID>
  </results_reference>
  <results_reference>
    <citation>Pearson MJ, Smart NA. Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2018 Jan;23(1):91-108. doi: 10.1007/s10741-017-9662-z.</citation>
    <PMID>29185161</PMID>
  </results_reference>
  <results_reference>
    <citation>Paneroni M, Simonelli C, Vitacca M, Ambrosino N. Aerobic Exercise Training in Very Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Am J Phys Med Rehabil. 2017 Aug;96(8):541-548. doi: 10.1097/PHM.0000000000000667. Review.</citation>
    <PMID>28099192</PMID>
  </results_reference>
  <results_reference>
    <citation>Piepoli MF. Exercise training in chronic heart failure: mechanisms and therapies. Neth Heart J. 2013 Feb;21(2):85-90. doi: 10.1007/s12471-012-0367-6.</citation>
    <PMID>23239451</PMID>
  </results_reference>
  <results_reference>
    <citation>Anderson L, Nguyen TT, Dall CH, Burgess L, Bridges C, Taylor RS. Exercise-based cardiac rehabilitation in heart transplant recipients. Cochrane Database Syst Rev. 2017 Apr 4;4:CD012264. doi: 10.1002/14651858.CD012264.pub2. Review.</citation>
    <PMID>28375548</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>July 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2011</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Ekkehard Gruenig</investigator_full_name>
    <investigator_title>Prof. Dr. med. Ekkehard Grünig</investigator_title>
  </responsible_party>
  <keyword>physical training</keyword>
  <keyword>remaining post-operative pulmonary vascular changes</keyword>
  <keyword>right ventricular pump function</keyword>
  <keyword>PEA</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

